ProMIS Neurosciences, Inc.
PMN
$7.55
$0.111.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.80M | 8.75M | 5.46M | 4.32M | 2.56M |
| Gross Profit | -9.80M | -8.75M | -5.46M | -4.32M | -2.56M |
| SG&A Expenses | 1.95M | 1.43M | 2.00M | -1.82M | 1.87M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.75M | 10.18M | 7.46M | 2.50M | 4.43M |
| Operating Income | -11.75M | -10.18M | -7.46M | -2.50M | -4.43M |
| Income Before Tax | -11.58M | -10.12M | -7.35M | -238.20K | 9.28M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.58M | -10.12M | -7.35M | -238.20K | 9.28M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.58M | -10.12M | -7.35M | -238.20K | 9.28M |
| EBIT | -11.75M | -10.18M | -7.46M | -2.50M | -4.43M |
| EBITDA | -- | -- | -- | -2.50M | -4.43M |
| EPS Basic | -5.93 | -7.26 | -5.27 | -0.17 | 7.72 |
| Normalized Basic EPS | -3.71 | -4.54 | -3.29 | 1.46 | 4.83 |
| EPS Diluted | -6.00 | -7.26 | -5.27 | -0.17 | 7.72 |
| Normalized Diluted EPS | -3.71 | -4.54 | -3.29 | 1.46 | 4.82 |
| Average Basic Shares Outstanding | 1.95M | 1.39M | 1.39M | 1.39M | 1.20M |
| Average Diluted Shares Outstanding | 1.95M | 1.39M | 1.39M | 1.39M | 1.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |